Deuterium Capital Management’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.11M Hold
15,425
8.27% 4
2025
Q4
$8.74M Hold
15,425
12.67% 3
2025
Q3
$6.9M Hold
15,425
9.99% 5
2025
Q2
$8.38M Hold
15,425
15.73% 3
2025
Q1
$7.64M Hold
15,425
17.01% 2
2024
Q4
$8.05M Sell
15,425
-7,575
-33% -$3.95M 21.09% 2
2024
Q3
$11.3M Buy
23,000
+5,000
+28% +$2.33M 20.73% 2
2024
Q2
$8.01M Hold
18,000
13.5% 2
2024
Q1
$7.18M Hold
18,000
12.81% 3
2023
Q4
$6.07M Hold
18,000
20.07% 1
2023
Q3
$5.26M Hold
18,000
12.64% 2
2023
Q2
$6.15M Hold
18,000
7.97% 3
2023
Q1
$4.6M Sell
18,000
-97
-0.5% -$23.9K 7.21% 2
2022
Q4
$4.8M Hold
18,097
12.72% 2
2022
Q3
$3.39M Sell
18,097
-97
-0.5% -$20.8K 14.15% 3
2022
Q2
$3.65M Hold
18,194
12.37% 3
2022
Q1
$5.49M Buy
18,194
+194
+1% +$56.7K 7.06% 4
2021
Q4
$6.47M Buy
+18,000
New +$6.19M 9.57% 3

Other funds holding ISRG

Deuterium Capital Management's ISRG Position: Q1 2026 in Review

Deuterium Capital Management held its Intuitive Surgical (ISRG) position steady in Q1 2026 at 15,425 shares worth $7.11M. The position accounts for 8.27% of the portfolio, ranked #4.

Deuterium Capital Management first reported a position in ISRG in Q4 2021 and has held it in 18 quarters since. The position peaked at $11.3M in Q3 2024. 2,305 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.

  • Deuterium Capital Management held 15,425 shares of Intuitive Surgical worth $7.11M as of Q1 2026.
  • Deuterium Capital Management left its Intuitive Surgical share count unchanged in Q1 2026.
  • Intuitive Surgical made up 8.27% of Deuterium Capital Management's portfolio in Q1 2026, its #4 holding.
  • Deuterium Capital Management first reported a position in Intuitive Surgical in Q4 2021 and has held it in 18 quarters since.
  • Deuterium Capital Management's Intuitive Surgical position peaked at $11.3M in Q3 2024.
  • 2,305 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.

Based on Deuterium Capital Management's 13F filing for Q1 2026, filed 14 May 2026.